10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64 | -19.0% | 1,546 | +8.8% | 0.00% | – |
| Q2 2023 | $79 | -13.2% | 1,421 | -12.9% | 0.00% | – |
| Q1 2023 | $91 | +62.5% | 1,632 | +7.0% | 0.00% | – |
| Q4 2022 | $56 | -99.9% | 1,525 | +15.1% | 0.00% | – |
| Q3 2022 | $38,000 | -99.0% | 1,325 | -98.5% | 0.00% | -100.0% |
| Q2 2022 | $3,990,000 | -33.7% | 88,179 | +11.5% | 0.01% | -8.3% |
| Q1 2022 | $6,014,000 | -35.6% | 79,055 | +26.1% | 0.01% | -45.5% |
| Q4 2021 | $9,338,000 | -1.0% | 62,691 | -3.2% | 0.02% | -8.3% |
| Q3 2021 | $9,431,000 | -43.0% | 64,782 | -23.3% | 0.02% | -38.5% |
| Q2 2021 | $16,543,000 | +0.1% | 84,483 | -7.4% | 0.04% | -13.3% |
| Q1 2021 | $16,522,000 | – | 91,281 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |